CHGCY(CHGCY)
CHGCY
No analyst ratings available
No analyst price targets available for CHGCY
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.37T | $1.59T |
| Low | $1.35T | $1.56T |
| High | $1.41T | $1.64T |
| EBITDA Avg | $634.70B | $734.10B |
| Low | $623.30B | $720.92B |
| High | $654.65B | $757.18B |
| EBIT Avg | $597.04B | $690.55B |
| Low | $586.32B | $678.15B |
| High | $615.82B | $712.26B |
| Net Income Avg | $490.74B | $628.75B |
| Low | $479.28B | $614.08B |
| High | $510.79B | $654.45B |
| EPS Avg | $149.09 | $191.03 |
| Low | $145.61 | $186.57 |
| High | $155.19 | $198.83 |
| Analysts (Rev / EPS) | 7 / 1 | 7 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $349.97B | $378.60B |
| Low | $341.17B | $369.08B |
| High | $358.79B | $388.14B |
| EBITDA Avg | $161.99B | $175.24B |
| Low | $157.92B | $170.84B |
| High | $166.07B | $179.66B |
| EBIT Avg | $152.38B | $164.85B |
| Low | $148.55B | $160.70B |
| High | $156.22B | $169.00B |
| Net Income Avg | — | — |
| Low | — | — |
| High | — | — |
| EPS Avg | — | — |
| Low | — | — |
| High | — | — |
| Analysts (Rev / EPS) | 3 / — | 3 / — |